The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 27, 2017

Filed:

May. 31, 2012
Applicants:

Bumsuk Hahm, Columbia, MO (US);

Young-jin Seo, Atlanta, GA (US);

Stephen Alexander, Columbia, MO (US);

Vijayan Madhuvanthi, Columbia, MO (US);

Inventors:

Bumsuk Hahm, Columbia, MO (US);

Young-Jin Seo, Atlanta, GA (US);

Stephen Alexander, Columbia, MO (US);

Vijayan Madhuvanthi, Columbia, MO (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/425 (2006.01); A01N 43/78 (2006.01); A61K 31/426 (2006.01); A61K 31/133 (2006.01); C12N 9/88 (2006.01); C12N 15/113 (2010.01); A61K 48/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/426 (2013.01); A61K 31/133 (2013.01); C12N 9/88 (2013.01); C12N 15/113 (2013.01); C12N 15/1137 (2013.01); C12N 15/1138 (2013.01); C12Y 401/02027 (2013.01); A61K 48/005 (2013.01); C12N 2310/14 (2013.01); C12N 2760/16111 (2013.01); C12N 2760/18411 (2013.01);
Abstract

The present invention relates to compounds and methods for the prevention or treatment of infections by negative strand RNA viruses, such as influenza virus and measles virus, wherein said compounds delay or inhibit viral replication by modulating the level or activity of a polypeptide involved in the synthesis or degradation of sphingosine-1-phosphate (S1P) in a cell, tissue, or subject. The methods involve administration of one or more compounds which modulate the level of gene expression, where the gene encodes a polypeptide involved in regulating the metabolic level of S1P, or modulate the level or activity of a polypeptide involved in regulating the metabolic level of S1P, such as sphingosine kinase (SK) and S1P lyase (SPL). Exemplary methods are directed towards reducing the level of SW by reducing the level or activity of one or more SKs, increasing the level or activity of one or more SPLs, or a combination of both steps.


Find Patent Forward Citations

Loading…